RTTNews | Dec 14, 2021 07:27AM EST

07:27 Tuesday, December 14, 2021 (RTTNews) - Alterity Therapeutics Announces First Regulatory Authorization To Proceed With ATH434 Phase 2 Clinical Trial

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved